Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$42.6K Buy
150
+25
+20% +$7.32K 0.06% 163
2023
Q4
$36K Hold
125
0.05% 166
2023
Q3
$33.6K Hold
125
0.05% 163
2023
Q2
$27.8K Hold
125
0.04% 176
2023
Q1
$30.2K Hold
125
0.05% 165
2022
Q4
$32.8K Hold
125
0.05% 160
2022
Q3
$28K Hold
125
0.05% 166
2022
Q2
$30K Hold
125
0.05% 159
2022
Q1
$30K Hold
125
0.04% 166
2021
Q4
$28K Buy
+125
New +$26.4K 0.04% 170

Other funds holding AMGN

Norwood Financial's AMGN Position: Q1 2024 in Review

Norwood Financial increased its Amgen (AMGN) stake by 20% in Q1 2024, buying an estimated $7.32K and bringing the position to 150 shares worth $42.6K. The position accounts for 0.06% of the portfolio, ranked #163.

Norwood Financial first reported a position in AMGN in Q4 2021 and has held it in 10 quarters since. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Norwood Financial held 150 shares of Amgen worth $42.6K as of Q1 2024.
  • Norwood Financial bought 25 Amgen shares in Q1 2024, an estimated $7.32K.
  • Amgen made up 0.06% of Norwood Financial's portfolio in Q1 2024, its #163 holding.
  • Norwood Financial first reported a position in Amgen in Q4 2021 and has held it in 10 quarters since.
  • 2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.